Showing 2,658 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

Achillion Achieves 100% SVR12 in Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102

Editor's pick
Achillion press release
9 February 2015
Hepatitis C treatment

Worldwide treatment of hepatitis C could be within sight at the right cost

Editor's pick
Imperial College press release
9 February 2015
Finance & funding

Obama Budget Boosts U.S. HIV and Hepatitis Funding, Cuts Global AIDS and TB

Editor's pick
HIVandHepatitis.com
9 February 2015
Access to healthcare

Portugal agrees to treat 13,000 hepatitis C patients

Editor's pick
Xinhua
9 February 2015
Hepatitis C treatment

What the 'Shocking' Gilead Discounts on its Hepatitis C Drugs Will Mean

Editor's pick
Wall Street Journal (blog)
5 February 2015
Hepatitis C treatment

Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion

Editor's pick
New York Times
5 February 2015
Hepatitis B

Hepatitis Quest Moves From C to B Under Former Gilead Executives

Editor's pick
Bloomberg
5 February 2015
Hepatitis C transmission & prevention

Hepatitis C more prevalent than HIV/AIDS or Ebola yet lacks equal attention

Editor's pick
Medical Xpress
5 February 2015
New & experimental hepatitis C treatment

Merck says hepatitis C drugs to lose breakthrough status

Editor's pick
Reuters
5 February 2015
Finance & funding

How Hepatitis C Is Shining A Light On Critical Gaps In Payment Reform

Editor's pick
Health Affairs (blog)
4 February 2015
Hepatitis C transmission & prevention

ChemSex and HCV transmission among UK MSM

Editor's pick
BMJ Group blogs
3 February 2015
Access to healthcare

Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries

Editor's pick
TAG
3 February 2015
Pharmaceutical industry

AbbVie Inc stock drops after expectations for Viekira Pak fall short

Editor's pick
Bidness Etc
2 February 2015
New & experimental hepatitis C treatment

AbbVie next-generation hepatitis C drugs look promising in early studies

News
30 January 2015
Access to healthcare

Hepatitis C drug access: Europe is the new Africa

Editor's pick
HIV i-Base
30 January 2015
Access to healthcare

Petition: Equitable access to HCV drugs

Editor's pick
Petitionbuzz
30 January 2015
Access to healthcare

MSF response to Gilead announcement on inclusion of hepatitis C drug GS-5816 in voluntary licence

Editor's pick
Médecins Sans Frontières press release
27 January 2015
New & experimental hepatitis C treatment

Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

Editor's pick
Gilead press release
27 January 2015
Hepatitis C treatment

German insurers win discounts on Gilead's Sovaldi

Editor's pick
Yahoo News
26 January 2015
Hepatitis C treatment

Merck discontinues Victrelis (boceprevir) voluntarily in the United States

Editor's pick
EATG
21 January 2015
Hepatitis C transmission & prevention

Vertical transmission of HCV: The next big treatment frontier

Editor's pick
EATG
20 January 2015
Hepatitis C symptoms & diagnosis

UNITAID publishes comprehensive review of detection and monitoring technologies for hepatitis C

Editor's pick
UNITAID press release
20 January 2015
Hepatitis C treatment

Gilead and AbbVie take hepatitis C battle to Europe

Editor's pick
Financial Times (free registration required)
20 January 2015
Access to healthcare

How India's Patent Office Destroyed Gilead's Global Game Plan

Editor's pick
Bloomberg Businessweek
19 January 2015